Background: Proper cell models for breast cancer primary tumors have long been the focal point in the cancer’s research. The genomic comparison between cell lines and tumors can investigate the similarity and dissimilarity and help to select right cell model to mimic tumor tissues to properly evaluate the drug reaction in vitro. In this paper, a comprehensive comparison in copy number variation (CNV), mutation, mRNA expression and protein expression between 68 breast cancer cell lines and 1375 primary breast tumors is conducted and presented. Results: Using whole genome expression arrays, strong correlations were observed between cells and tumors. PAM50 gene expression differentiated them into four major breast cancer subtypes: Lumina...
Background Breast cancer cell lines are widely used tools to investigate breast cancer biology and t...
We used cDNA microarrays to explore the variation in expression of approximately 8,000 unique genes ...
exome sequencing, mRNA arrays, microRNA sequencing and reverse phase protein arrays. Our ability to ...
SummaryRecent studies suggest that thousands of genes may contribute to breast cancer pathophysiolog...
BACKGROUND:Breast cancer cell lines have been used widely to investigate breast cancer pathobiology ...
which permits unrestricted use, distribution, and reproduction in any medium, provided the original ...
Breast cancer cell lines have been used widely to investigate breast cancer pathobiology and new the...
We analysed primary breast cancers by genomic DNA copy number arrays, DNA methylation, exome sequenc...
Breast cancer has for long been recognized as a highly diverse tumor group, but the underlying genet...
Cell lines derived from human tumors have historically served as the primary experimental model syst...
Summary: Patient-derived cell lines are often used in pre-clinical cancer research, but some cell li...
It is now accepted that breast cancer is not a single disease, but instead it is composed of a spect...
Background: Breast cancer (BC), one of the most frequent human tumors, is genetically and histologic...
Abstract Background Development of therapies for patients with BRCA1 mutations has been hampered by ...
Failure to adequately characterize cell lines, and understand the differences between in vitro and i...
Background Breast cancer cell lines are widely used tools to investigate breast cancer biology and t...
We used cDNA microarrays to explore the variation in expression of approximately 8,000 unique genes ...
exome sequencing, mRNA arrays, microRNA sequencing and reverse phase protein arrays. Our ability to ...
SummaryRecent studies suggest that thousands of genes may contribute to breast cancer pathophysiolog...
BACKGROUND:Breast cancer cell lines have been used widely to investigate breast cancer pathobiology ...
which permits unrestricted use, distribution, and reproduction in any medium, provided the original ...
Breast cancer cell lines have been used widely to investigate breast cancer pathobiology and new the...
We analysed primary breast cancers by genomic DNA copy number arrays, DNA methylation, exome sequenc...
Breast cancer has for long been recognized as a highly diverse tumor group, but the underlying genet...
Cell lines derived from human tumors have historically served as the primary experimental model syst...
Summary: Patient-derived cell lines are often used in pre-clinical cancer research, but some cell li...
It is now accepted that breast cancer is not a single disease, but instead it is composed of a spect...
Background: Breast cancer (BC), one of the most frequent human tumors, is genetically and histologic...
Abstract Background Development of therapies for patients with BRCA1 mutations has been hampered by ...
Failure to adequately characterize cell lines, and understand the differences between in vitro and i...
Background Breast cancer cell lines are widely used tools to investigate breast cancer biology and t...
We used cDNA microarrays to explore the variation in expression of approximately 8,000 unique genes ...
exome sequencing, mRNA arrays, microRNA sequencing and reverse phase protein arrays. Our ability to ...